Opioid Use Disorder
Conditions
Keywords
opioid use disorder, behavioral activation, primary care, buprenorphine
Brief summary
The overall purpose of this pilot study is to evaluate the feasibility and acceptability of values-based behavioral activation (BA) as an adjunct intervention for patients receiving medications for opioid use disorder (OUD) in primary care. Researcher will evaluate the following aims: 1) examine the feasibility of BA for OUD in primary care, 2) examine whether the BA intervention and study requirements are acceptable to participants, and 3) determine the psychometric properties of the outcome measures in people with OUD. Participants will complete 4-6 brief counseling sessions over the course of 12 weeks. During the first session, participants will discuss values and recovery outcomes important to them. Next, they will set 2-3 personal goals to work on before the next BA session. At the follow-up sessions, participants will update the counselor on progress made or challenges experienced. Personal values will be reviewed and participant goals updated. Study measures (surveys and urine drug tests) will be completed at the start, partway through, and at the end of the intervention.
Interventions
BEHAVIORALValues-based Behavioral Activation
Initially, patients complete a values assessment in which they identify personal values in various life domains. With the assistance of a clinician, patients set incremental behavior goals to move their daily actions to better align with their self-reported values. Goal completion allows the patient to achieve outcomes consistent with recovery, and they potentially experience enjoyment, self-efficacy, and confidence as they progress through the treatment.
Sponsors
University of Minnesota
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
single-arm, pre/post pilot trial
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* At least 18 years of age. * Diagnosis of opioid use disorder. * Have an active prescription for buprenorphine-naloxone (Suboxone) for at least one month. * Patient at Broadway Family Medicine (BFM)
Exclusion criteria
* Concurrent individual psychotherapy with a psychologist or counselor at least monthly * Active suicidal ideation (intention, plan, or attempt in the past 30 days, as determined by chart review) * Dementia, developmental disabilities, or cognitive functioning that is too low to participate in therapy, as determined by chart review
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Feasibility of Recruitment | 3 months from baseline | % of patients approached who consent |
| Recruitment Pace | 3 months following intervention | Average # of patients enrolled per week |
| Retention Percent | 3 months following intervention | % of consented patients who complete the study |
| Treatment Satisfaction | 3 months following intervention | Average satisfaction score |
Countries
United States
Outcome results
None listed